Sort
261,768 grants matching “gene therapy”
Vascular Growth and Regeneration
$940,801Luisa Iruela-Arispe · Northwestern University At Chicago · R35 · FY2024 · HL
From pathogenesis to new therapeutic targets in Diffuse Large B cell Lymphoma
$940,800Riccardo Dalla-Favera · Columbia University Health Sciences · R35 · FY2022 · CA
New and Disruptive Therapeutic Approaches to Target Fundamental Molecular Mechanisms Underlying Atrial Fibrillation
$940,799Rishi Arora · Northwestern University At Chicago · R35 · FY2024 · HL
Translating genomic discoveries to improved outcomes for high risk acute leukemia
$940,706Charles G. Mullighan · St. Jude Children'S Research Hospital · R35 · FY2020 · CA
Metabolic Tumor Suppressors in Renal Cancer: Unprecedented Roles in Disease Progression
$940,683M. Celeste Simon · University Of Pennsylvania · R35 · FY2022 · CA
A new model of accelerated immune aging in HIV-infected drug users
$940,675Melanie Maria Ott · J. David Gladstone Institutes · DP1 · FY2015 · DA
Functional Analysis of Oncogenic Networks in Primary Organoids
$940,609Calvin J Kuo · Stanford University · U01 · FY2013 · CA
Genetic Determinants of Epilepsy in Murine Systems
$940,521Tristan T Sands · Columbia University Health Sciences · R01 · FY2024 · NS
The Role of Transforming Growth Factor Beta (TGFbeta) in Promoting Allergic Inflammation
$940,379Pamela Guerrerio · National Institute Of Allergy And Infectious Diseases · ZIA · FY2017 · AI
Novel methods to improve nuclease mediated homologous recombination
$940,327Jifeng Zhang · Atgc, Inc. · R42 · FY2023 · GM
Optimizing eCD4-Ig for eradication and a functional cure
$940,275Michael R. Farzan · Scripps Florida · R01 · FY2019 · AI
National Ophthalmic Disease Genotyping and Phenotyping Network - eyeGENE
$940,101Santa Tumminia · National Eye Institute · ZIC · FY2014 · EY
Single-cell genomic profiling to identify immune signatures of bacterial sepsis in humans
$939,914Marcia B Goldberg · Massachusetts General Hospital · R01 · FY2023 · AI
Identifying Genes for Type 2 Diabetes: FUSION
$939,832Michael Boehnke · University Of Michigan At Ann Arbor · U01 · FY2013 · DK
Mutations of Chromatin and its Modifying Machineries in Malignancies
$939,694Ali Shilatifard · Northwestern University At Chicago · R35 · FY2025 · CA
Early neonatal treatment and immune quiescence
$939,676Louise Kuhn · Columbia University Health Sciences · U01 · FY2014 · HD
Stress Management of Cryptococcal Pathogens
$939,657Kyung Kwon-Chung · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
Lentivirus-based Immunogene Therapy for HIV Infection
$939,640University Of Pennsylvania · U19 · FY2005 · AI
Hybrid Molecules Designed to Enhance Antibiotic Activity
$939,605George E Wright · Glsynthesis, Inc. · R44 · FY2007 · AI
Promoting Kidney Transplantation Tolerance Through Novel Immunomodulation and Cellular Therapy
$939,602Andrew B Adams · University Of Minnesota · U19 · FY2024 · AI
Innovating Yeast and Human Genetics Approaches to Define Mechanisms of Neurodegenerative Disease
$939,520Aaron D. Gitler · Stanford University · R35 · FY2017 · NS
Development of a biomimetic small molecule therapeutic for neovascular retinal diseases
$939,493Amy Wang · Eyemedix, Inc. · R44 · FY2019 · EY
Development of a biomimetic small molecule therapeutic for neovascular retinal diseases
$939,493Amy Wang · Eyemedix, Inc. · R44 · FY2020 · EY
Tie2-driven vascular control in critical illness
$939,488Samir M Parikh · Beth Israel Deaconess Medical Center · R35 · FY2018 · HL
Liver Pathobiology and Gene Therapy Research Core Center
$939,375Allan W Wolkoff · Albert Einstein College Of Medicine, Inc · P30 · FY2015 · DK